Zobrazeno 1 - 10
of 225
pro vyhledávání: '"Eiichi, Nakayama"'
Autor:
Yuka Maeda, Hisashi Wada, Daisuke Sugiyama, Takuro Saito, Takuma Irie, Kota Itahashi, Kodai Minoura, Susumu Suzuki, Takashi Kojima, Kazuhiro Kakimi, Jun Nakajima, Takeru Funakoshi, Shinsuke Iida, Mikio Oka, Teppei Shimamura, Toshihiko Doi, Yuichiro Doki, Eiichi Nakayama, Ryuzo Ueda, Hiroyoshi Nishikawa
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Elimination of regulatory T cells via the anti-CCR4 monoclonal antibody, mogamulizumab, is expected to augment anti-tumour immune response. Authors show here that although regulatory T cell targeting is successful, clinical improvement remains minima
Externí odkaz:
https://doaj.org/article/a5114e3a54eb4c2488d410e0289e8399
Autor:
Eiichi Nakayama, Mikio Oka, Junya Fukuoka, Takashi Hori, Yoshinori Doki, Tomonori Tanaka, Yumi Nishio, Midori Isobe, Ryohei Nozawa, Koji Kurose, Yoshihiro Ohue
Table S1 and Table S2- Patients' characteristics. Table S3 - Cell lines. Table S4 - Antibodies used. Table S5 - Expression of PD-L1 and Galectin-9 in lung cancer. Table S6 - Expression of XAGE1 in lung cancer. Table S7 - Cut-off values for each T-cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7700c54294a84fb3224aae31d17bc26d
https://doi.org/10.1158/2326-6066.22537991.v1
https://doi.org/10.1158/2326-6066.22537991.v1
Autor:
Sacha Gnjatic, Lloyd J. Old, Gerd Ritter, Elke Jäger, Jonathan Melamed, James P. Allison, Caroline Savage, Victor E. Reuter, Sumit K. Subudhi, Susan Slovin, Peter T. Scardino, Howard Scher, Brett Carver, Yuichi Obata, Toshiaki Ishida, Eiichi Nakayama, Erika Ritter, Megan Holz, Denise Frosina, Achim A. Jungbluth, Bernardo Sgarbi Reis
PDF file 90K, Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16dc65e1ac690c49124931e31ae4c177
https://doi.org/10.1158/1078-0432.22452491
https://doi.org/10.1158/1078-0432.22452491
Autor:
Eiichi Nakayama, Ryuzo Ueda, Mikio Oka, Heiichiro Udono, Hiroyoshi Nishikawa, Kazuhiro Kakimi, Takeru Funakoshi, Midori Isobe, Susumu Suzuki, Toshihiko Doi, Takashi Kojima, Takashi Ishida, Shinsuke Iida, Hisashi Wada, Yoshihiro Ohue, Koji Kurose
Antibody response and CD4 and CD8 T-cell responses during treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c15efe06e1a5b51293545b3b4544bd
https://doi.org/10.1158/1078-0432.22459527
https://doi.org/10.1158/1078-0432.22459527
Autor:
Eiichi Nakayama, Mikio Oka, Akiko Uenaka, Minoru Fukuda, Midori Isobe, Yumi Nishio, Hirofumi Matsumoto, Yu Mizote, Koji Kurose, Yoshihiro Ohue
Representative results of analyses of CD4 (A) and CD8 (B) T cells expressing T cell activation and inhibitory molecules in PBMCs from an XAGE1 (GAGED2a) antibody-positive patient, KLU456 by FACS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e8cdbbdde61d4e88e9d4d3322391793
https://doi.org/10.1158/1078-0432.22460087
https://doi.org/10.1158/1078-0432.22460087
Autor:
Eiichi Nakayama, Ryuzo Ueda, Mikio Oka, Heiichiro Udono, Hiroyoshi Nishikawa, Kazuhiro Kakimi, Takeru Funakoshi, Midori Isobe, Susumu Suzuki, Toshihiko Doi, Takashi Kojima, Takashi Ishida, Shinsuke Iida, Hisashi Wada, Yoshihiro Ohue, Koji Kurose
Patient characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ea4ba1d20f9a7d5acbd5be9fef622b1
https://doi.org/10.1158/1078-0432.22459524
https://doi.org/10.1158/1078-0432.22459524
Autor:
Eiichi Nakayama, Ryuzo Ueda, Mikio Oka, Heiichiro Udono, Hiroyoshi Nishikawa, Kazuhiro Kakimi, Takeru Funakoshi, Midori Isobe, Susumu Suzuki, Toshihiko Doi, Takashi Kojima, Takashi Ishida, Shinsuke Iida, Hisashi Wada, Yoshihiro Ohue, Koji Kurose
Immune response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb4680d070f8d4d976f396a57e360f22
https://doi.org/10.1158/1078-0432.22459521.v1
https://doi.org/10.1158/1078-0432.22459521.v1
Autor:
Eiichi Nakayama, Ryuzo Ueda, Mikio Oka, Heiichiro Udono, Hiroyoshi Nishikawa, Kazuhiro Kakimi, Takeru Funakoshi, Midori Isobe, Susumu Suzuki, Toshihiko Doi, Takashi Kojima, Takashi Ishida, Shinsuke Iida, Hisashi Wada, Yoshihiro Ohue, Koji Kurose
Clinical course of 3 NSCLC patients evaluated as SD at 12 weeks after treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::292bc6305f62fea1fab80b5c047cc505
https://doi.org/10.1158/1078-0432.22459533.v1
https://doi.org/10.1158/1078-0432.22459533.v1
Autor:
Eiichi Nakayama, Ryuzo Ueda, Mikio Oka, Heiichiro Udono, Hiroyoshi Nishikawa, Kazuhiro Kakimi, Takeru Funakoshi, Midori Isobe, Susumu Suzuki, Toshihiko Doi, Takashi Kojima, Takashi Ishida, Shinsuke Iida, Hisashi Wada, Yoshihiro Ohue, Koji Kurose
The changes in the specific populations in PBMCs, lymphocytes and CD4 T-cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::786413231fa78c1135386ecae2b3bc2f
https://doi.org/10.1158/1078-0432.22459530
https://doi.org/10.1158/1078-0432.22459530
Autor:
Eiichi Nakayama, Mikio Oka, Akiko Uenaka, Minoru Fukuda, Midori Isobe, Yumi Nishio, Hirofumi Matsumoto, Yu Mizote, Koji Kurose, Yoshihiro Ohue
OS of the advanced adenocarcinoma patients with EGFRwt or EGFRmt tumors (A), and with XAGE1 (GAGED2a) antigen-positive EGFRwt or EGFRmt tumors and antibody, and XAGE1 (GAGED2a) antigen-negative EGFRmt tumors (B).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96dd30d9b654dc811d3a56eb6ea748b9
https://doi.org/10.1158/1078-0432.22460081
https://doi.org/10.1158/1078-0432.22460081